STOCK TITAN

Large Vivani (VANI) shareholder Gregg Williams adds 1.59M shares in $2.0M purchase

Filing Impact
(Very High)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Vivani Medical, Inc. director and significant shareholder Gregg Williams bought 1,587,301 shares of common stock at $1.26 per share in a private sale transaction. The footnotes state the gross amount for this transaction was $1,999,999.26.

After these transactions, Williams is reported as owning a total of 39,330,985 Vivani shares directly and indirectly. This includes 4,799,200 shares held personally and additional holdings through several trusts and LLCs over which he has voting and dispositive power.

Positive

  • None.

Negative

  • None.

Insights

Large Vivani holder adds $2.0M of stock in a private purchase.

The filing shows Gregg Williams, a director and more than 10% owner of Vivani Medical, completed an open-market-style private purchase of 1,587,301 common shares at $1.26 per share, tied to a Share Purchase Agreement dated August 11, 2025.

Footnotes indicate aggregate gross consideration of $1,999,999.26 for this transaction. Following it, Williams’ beneficial ownership is 39,330,985 shares across direct holdings and multiple trusts and LLCs where he has voting and dispositive power, suggesting this buy modestly increases an already substantial position.

Insider Williams Gregg
Role null
Bought 1,587,301 shs ($2.00M)
Type Security Shares Price Value
Purchase Common Stock 1,587,301 $1.26 $2.00M
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 34,531,785 shares (Indirect, See footnote); Common Stock — 4,799,200 shares (Direct, null)
Footnotes (1)
  1. The reporting person purchased 1,587,301 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of August 11, 2025 at a price of $1.26 per share, which was the last reported sale price of the Issuer's common stock on the Nasdaq on August 10, 2025 (the day immediately prior to August 11, 2025). The gross proceeds from this private sale transaction were $1,999,999.26. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote. The reporting person owns 39,330,985 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 32,406,033 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.
Shares purchased 1,587,301 shares Common stock bought in private sale at $1.26 per share
Purchase price $1.26 per share Price equals last reported Nasdaq sale on August 10, 2025
Gross transaction amount $1,999,999.26 Gross proceeds for the private sale transaction
Total beneficial ownership 39,330,985 shares Shares owned directly and indirectly after transaction
Directly owned shares 4,799,200 shares Common stock held personally by Gregg Williams
Trust-held shares 32,406,033 shares Common stock owned by Gregg G. Williams 2006 Trust
open-market purchase financial
"transaction_action": "open-market purchase""
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
Share Purchase Agreement financial
"as disclosed in the Share Purchase Agreement dated as of August 11, 2025"
A share purchase agreement is a written contract that outlines the terms and conditions for buying and selling shares of a company. It specifies details like the price, number of shares, and any special conditions, ensuring both buyer and seller agree on the transaction. For investors, it provides clarity and legal protection, making sure the purchase is clear and enforceable.
gross proceeds financial
"The gross proceeds from this private sale transaction were $1,999,999.26."
The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.
generation-skipping trust financial
"Sam B. Williams 1995 Generation-Skipping Trust."
voting and dispositive power financial
"Gregg Williams has voting and dispositive power over all of these shares."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Williams Gregg

(Last)(First)(Middle)
C/O VIVANI MEDICAL, INC.
1350 S. LOOP ROAD

(Street)
ALAMEDA CALIFORNIA 94502

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Vivani Medical, Inc. [ VANI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/15/2026P(1)1,587,301A$1.2634,531,785ISee footnote(2)
Common Stock4,799,200D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The reporting person purchased 1,587,301 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of August 11, 2025 at a price of $1.26 per share, which was the last reported sale price of the Issuer's common stock on the Nasdaq on August 10, 2025 (the day immediately prior to August 11, 2025). The gross proceeds from this private sale transaction were $1,999,999.26. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote.
2. The reporting person owns 39,330,985 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 32,406,033 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.
/s/ Anthony Baldor, Attorney-in-fact05/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Gregg Williams report for Vivani Medical (VANI)?

Gregg Williams reported buying 1,587,301 Vivani shares. The shares were purchased in a private sale at $1.26 per share under a Share Purchase Agreement, reflecting a total transaction amount of $1,999,999.26 as disclosed in the footnotes.

At what price did Gregg Williams acquire Vivani (VANI) shares in this Form 4?

Williams acquired the shares at $1.26 per share. The price matched the last reported Nasdaq sale price of Vivani’s common stock on August 10, 2025, immediately before the Share Purchase Agreement date noted in the filing footnotes.

How many Vivani (VANI) shares does Gregg Williams own after this transaction?

The filing reports Williams owning 39,330,985 shares after the transaction. This total combines 4,799,200 shares held directly with additional shares held through several trusts and LLCs over which Williams has voting and dispositive power.

What was the total dollar amount of Gregg Williams’ recent Vivani (VANI) share purchase?

The footnotes state gross proceeds of $1,999,999.26 for the purchase. This amount reflects 1,587,301 shares of Vivani common stock acquired in a private sale transaction at $1.26 per share under a Share Purchase Agreement.

How are Gregg Williams’ Vivani (VANI) holdings structured after the Form 4 transaction?

Williams holds Vivani shares both directly and through entities. The filing cites 4,799,200 shares owned personally and additional shares held by a 2006 trust, two LLCs, and a 1995 generation-skipping trust, totaling 39,330,985 shares under his voting and dispositive control.